Researchers Suggest Caution in Treating Lupus Patients With Early, Higher-Dose Prednisone
No abstract available (Source: Lippincott's Bone and Joint Newsletter)
Source: Lippincott's Bone and Joint Newsletter - November 19, 2016 Category: Orthopaedics Tags: Trends and Innovations Source Type: news

Amgen Announces Top-Line Results From Phase 3 KYPROLIS ® (Carfilzomib) CLARION Study In Newly Diagnosed Multiple Myeloma Patients
Amgen to Hold Analyst Call Today at 8:30 a.m. ET THOUSAND OAKS, Calif., Sept. 27, 2016 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced top-line results of the Phase 3 CLARION trial, which evaluated an investigational regimen of KYPROLIS® (carfilzomib), melphalan and prednisone (KMP) versus Velcade® (bortezomib), melphalan and prednisone (VMP) for 54 weeks in patients with newly diagnosed multiple myeloma who were ineligible for hematopoietic stem-cell transplant. The trial did not meet the primary endpoint of superiority in progression-free survival (PFS) (median PFS 22.3 months for KMP versus 22.1 months for ...
Source: Amgen News Release - September 27, 2016 Category: Pharmaceuticals Tags: Uncategorized Source Type: news

Deflazacort Improves Muscle Strength in Duchenne MD Deflazacort Improves Muscle Strength in Duchenne MD
The drug showed efficacy similar to that of prednisone, but significantly less weight gain, in a trial conducted more than 20 years ago. The FDA has accepted the company ' s NDA and granted a priority review.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 8, 2016 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news

Humira Provides Effective, Non-Steroid Alternative for Eye Inflammation
Contact: Amara Omeokwe Phone: 919-681-4239 Email:amara.omeokwe@duke.eduhttps://www.dukehealth.orgHumira Provides Effective, Non-Steroid Alternative for Eye InflammationEMBARGOED FOR RELEASE until 5 p.m. (ET) on Wednesday, September 7, 2016DURHAM, N.C. -- Patients suffering from noninfectious uveitis, a group of diseases that causes eye inflammation, can get effective treatment from a corticosteroid alternative that has previously been approved for treatment of arthritis and Crohn ’s disease, according to a study led by a Duke Health researcher.The Food& Drug Administration recently approved the additional use of adal...
Source: DukeHealth.org: Duke Health Features - September 8, 2016 Category: Pediatrics Tags: Duke Medicine Source Type: news

Feline Pancreatitis
Feline pancreatitis is inflammation of a cat's pancreas that can disrupt its normal functions and cause other symptoms as well. An inflamed pancreas is a serious problem, because the organ serves two vital functions in the body. It produces hormones -- insulin and glucagon -- that balance blood sugar. It also produces digestive enzymes such as amylase, lipase, and proteases, which enable the body to use carbohydrates, fats and proteins for energy. Symptoms of Pancreatitis in Cats In cats with pancreatitis, there are few overt symptoms. The most common signs are lethargy and lack of appetite. Since cats naturally sleep a ...
Source: Healthy Living - The Huffington Post - August 2, 2016 Category: Consumer Health News Source Type: news

prednisone (Prednisone Intensol, Rayos)
Title: prednisone (Prednisone Intensol, Rayos) < br / > Category: Medications < br / > Created: 12/31/1997 12:00:00 AM < br / > Last Editorial Review: 7/28/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - July 28, 2016 Category: Rheumatology Source Type: news

Finding A Cure Wouldn’t Mean We’ve Defeated Cancer
WebMD wasn't a research option when Ivy Brown was diagnosed with Hodgkin's lymphoma in 1974, so her mother looked up her 12-year-old daughter's condition the old-fashioned way, in a hardcover medical volume. "It just said 'fatal,'" Brown explained. Having moved the family to London a month earlier, Brown's parents were still trying to liaise with her pediatrician in the U.S. "My father told me recently that he was sleeping with the phone on his stomach because of the time change," she said. "They were as scared as you can be when you have a child who you think you might lose," Brown explained. "It was devastating for ...
Source: Healthy Living - The Huffington Post - June 29, 2016 Category: Consumer Health News Source Type: news

Finding A Cure Wouldn’t Mean We’ve Defeated Cancer
WebMD wasn't a research option when Ivy Brown was diagnosed with Hodgkin's lymphoma in 1974, so her mother looked up her 12-year-old daughter's condition the old-fashioned way, in a hardcover medical volume. "It just said 'fatal,'" Brown explained. Having moved the family to London a month earlier, Brown's parents were still trying to liaise with her pediatrician in the U.S. "My father told me recently that he was sleeping with the phone on his stomach because of the time change," she said. "They were as scared as you can be when you have a child who you think you might lose," Brown explained. "It was devastating for ...
Source: Science - The Huffington Post - June 29, 2016 Category: Science Source Type: news

Everolimus R-CHOP combination safe for treating diffuse large B-cell lymphoma
The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study. R-CHOP is a combination of drugs used to treat lymphoma. The combination includes rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 29, 2016 Category: Science Source Type: news

Everolimus R-CHOP combination safe for treating diffuse large B-cell lymphoma
(Mayo Clinic) The targeted therapy everolimus may be safely combined with R-CHOP for new, untreated diffuse large B-cell lymphoma according to the results of a pilot study by Mayo Clinic researchers published in the Lancet Haematology. R-CHOP is a combination of drugs used to treat lymphoma. The combination includes rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - June 29, 2016 Category: Cancer & Oncology Source Type: news

Prednisone (Prednisone Tablets, USP) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 16, 2016 Category: Drugs & Pharmacology Source Type: news

Spring health cheat sheet
The beginning of spring often brings warm weather and hours of outdoor fun, and many common winter infections recede. Unfortunately, spring weather can bring its own health challenges. As soon as the trees and flowers bloom, flowers bud and the grass grows, susceptible children will start to display symptoms of seasonal allergies. Seasonal allergies cause sneezing, runny nose and itchy red eyes and can trigger flares of asthma and eczema. As children spend more time outdoors, parents also need to watch for exposure to ticks, poison ivy and excess sun. Read on for the parents’ guide to spring health. Seasonal allergies: ...
Source: Thrive, Children's Hospital Boston - March 29, 2016 Category: Pediatrics Authors: Carolyn Sax Tags: Health & Wellness Parenting allergies asthma Carolyn Sax conjunctivitis lyme disease poion ivy sunburn Source Type: news

Benefits of anti-TNF treatment for psoriatic arthritis highlighted by study
This study was significant as it utilised data from patients in a real-world setting, rather than controlled test conditions. This provides doctors with a clearer view of how drugs work in routine clinical practice.A total of 420 biologic-naive patients with psoriatic arthritis, who were beginning treatment with the anti-TNF therapies adalimumab, etanercept or infliximab, were enrolled in the trial, with their progress followed over four years.Attention was paid to drug survival rates - the number of people remaining on treatment after a given period - as well as how many of the patients continued to rely on glucocorticoid...
Source: Arthritis Research UK - March 28, 2016 Category: Rheumatology Source Type: news

Benlysta Found Steroid-Sparing in Lupus (CME/CE)
(MedPage Today) -- Modest effects in prednisone dose reduction seen in post-hoc analyses (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 26, 2016 Category: Primary Care Source Type: news

Greater survival benefit shown in men with early and less aggressive mCRPC treated with Zytiga® plus prednisone
Janssen announced that data from a post-hoc analysis of the Phase III COU-AA-302 trial showed that ZYTIGA® plus prednisone provided an 11.8 months overall survival benefit, compared to an active control of placebo plus prednisone, in men with early and less aggressive chemotherapy-naïve metastatic castration-resistant prostate cancer (Source: Pharmacy Europe)
Source: Pharmacy Europe - March 14, 2016 Category: Drugs & Pharmacology Authors: Annabel De Coster Tags: *** Editor's Pick Clinical trials Practical therapeutics Oncology Patient care advanced prostate cancer COU-AA-302 trial European Association of Urology Latest News mCRPC Zytiga Source Type: news